Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2014
Total Assets: $167.57B
Liabilities Breakdown FY2014
Total Liabilities: $95.94B
Asset Breakdown
Total Assets: $167.57B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.34B | 2.0% |
| Accounts Receivable | $8.40B | 5.0% |
| Inventory | $5.66B | 3.4% |
| Property, Plant & Equipment | $11.76B | 7.0% |
| Goodwill | $42.07B | 25.1% |
| Intangible Assets | $35.17B | 21.0% |
| Other Assets | $61.16B | 36.5% |
Liabilities Breakdown
Total Liabilities: $95.94B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.21B | 3.3% |
| Long-Term Debt | $31.54B | 32.9% |
| Other Liabilities | $61.19B | 63.8% |